Vericel (VCEL) Interest Expenses (2010 - 2026)
Vericel's (VCEL) quarterly Interest Expenses came in at $160000.0 in Q1 2026, up 4.58% year-on-year from $153000.0 in Q1 2025, and down 1.23% quarter-over-quarter from $162000.0 in Q4 2025.
Vericel (VCEL) Interest Expenses (2010 - 2026) Analysis & Trends
Vericel has disclosed Interest Expenses across 17 years of filings, most recently posting $160000.0 for Q1 2026.
- Interest Expenses for Q1 2026 came in at $160000.0, up 4.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $637000.0 (up 3.75% YoY), and the FY2025 annual result was $630000.0, up 2.61% from the prior year.
- Interest Expenses came in at $160000.0 for Q1 2026 at Vericel, down from $162000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $223000.0 in Q4 2022 to a low of $18000.0 in Q1 2022.
- The 5-year median for Interest Expenses is $153000.0 (2024), against an average of $139411.8.
- Across the five-year window, Interest Expenses surged 22200.0% in 2022 and sank 30.04% in 2023, its largest moves.
- Vericel's Interest Expenses stood at $223000.0 in 2022, then tumbled by 30.04% to $156000.0 in 2023, then dropped by 1.28% to $154000.0 in 2024, then grew by 5.19% to $162000.0 in 2025, then retreated by 1.23% to $160000.0 in 2026.
- The last three Interest Expenses figures came in at $160000.0 (Q1 2026), $162000.0 (Q4 2025), and $158000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 160,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 160,000.00 |
| Mar 31, 2026 | 160,000.00 |
| Dec 31, 2025 | 162,000.00 |
| Dec 31, 2025 | 162,000.00 |
| Sep 30, 2025 | 158,000.00 |
| Sep 30, 2025 | 158,000.00 |
| Jun 30, 2025 | 157,000.00 |
| Jun 30, 2025 | 157,000.00 |
| Mar 31, 2025 | 153,000.00 |
| Mar 31, 2025 | 153,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Sep 30, 2024 | 154,000.00 |
| Sep 30, 2024 | 154,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Dec 31, 2023 | 156,000.00 |
| Dec 31, 2023 | 156,000.00 |